ArticleFrontiers in neurology
Efficacy observation of electromyography-guided targeted injection of swallowing muscles for treating dysphagia resulting from medullary paralysis.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To observe the clinical efficacy of electromyography (EMG)-guided targeted mecobalamin injections for treating dysphagia resulting from medullary paralysis and to investigate effective dysphagia management strategies. Methods: This study was a prospective randomized controlled trial. A total of 110 patients with dysphagia due to post-stroke bulbar palsy were enrolled at Baoding No.1 Central Hospital from February 2017 to December 2020. Patients were randomly assigned using a random number table to either a control group ( Results: The treatment group showed a significantly higher overall response rate on the WST than the control group ( Conclusion: EMG-guided targeted injection of mecobalamin into swallowing muscles is an effective adjunctive strategy for enhancing swallowing function in patients with dysphagia due to post-stroke medullary paralysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.